ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 442,15
2,20%
Dow Jones
43 085,07
0,83%
DAX
20 198,28
1,45%
Brent Oil
76,485
-0,03%
Bitcoin
102 286,66
4,03%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. Revive Therapeutics Ltd (QB) (RVVTF) Cours

Revive Therapeutics Ltd (QB)

Revive Therapeutics Ltd (QB) (RVVTF)

USOTC
0,00575
0,0002
( 3,60% )
Mis à jour : 17:14:10
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
0,00575
Prix Achat
0,0055
Prix Vente
0,006
Volume échangé
171 723
0,0055 Fourchette du Jour 0,00588
0,005 Plage de 52 semaines 0,036
Cap du marché
2,407M
Clôture Veille
0,00555
Ouverture
0,0058
Dernière Transaction
1000
@
0.00575
Dernière heure de transaction
17:14:10
Volume financier
US$ 985
VWAP
0,005738
Volume moyen (3 m)
498 557
Actions en circulation
418 564 269
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-5,97
Bénéfice par action (BPA)
-0,01
Chiffre d'affairess
-
Bénéfice net
-5,62M

À propos de Revive Therapeutics Ltd (QB)

Secteur
Pharmaceutical Preparations
Industrie
Unit Inv Tr, Closed-end Mgmt
Site Web
www.revivethera.com
Siège social
Toronto, Ontario, Can
Fondé
2014
Revive Therapeutics Ltd (QB) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker RVVTF. Le dernier cours de clôture d'Revive Therapeutics (QB) était de US$0,01. Au cours de la dernière année, les actions de Revive Therapeutics (QB) ont été négociées dans une fourchette de prix de US$ 0,005 à US$ 0,036.

Revive Therapeutics (QB) compte actuellement 418 564 269 actions en circulation. La capitalisation boursière d'Revive Therapeutics (QB) est de US$2,32 million. Revive Therapeutics (QB) a un ratio cours/bénéfice (ratio PE) de -5.97.

RVVTF Dernières nouvelles

Plus de nouvelles

Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19

  Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19   TORONTO, Canada -- April 18, 2022 -- InvestorsHub NewsWire -- Revive...

18 Avril 2022
InvestorsHub NewsWire

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

  Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   TORONTO, Canada -- April 12, 2022 -- InvestorsHub NewsWire -- Revive...

12 Avril 2022
InvestorsHub NewsWire

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   Expected to seek DSMB approval to proceed with EUA application to the FDA in...

29 Mars 2022
InvestorsHub NewsWire

HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research

                              HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive...

24 Février 2022
InvestorsHub NewsWire

Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation

 Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation  TORONTO, February 15, 2022 -- Revive...

16 Février 2022
InvestorsHub NewsWire

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19Ethics Committee approval to proceed with Phase 3 clinical trial in Turkey13 clinical sites selected to...

14 Février 2022
InvestorsHub NewsWire

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 701 subjects dosed to date Initiating enrollment activities in Turkey as part of its...

19 Janvier 2022
InvestorsHub NewsWire

Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

 Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs IRB approval to initiate Phase 2 study for methamphetamine abuse disorders Advancing psilocybin oral thin film...

17 Janvier 2022
InvestorsHub NewsWire

Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19

 Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19 Approximately 700 subjects participated in the enrollment periodExpected to begin subject enrollment...

07 Janvier 2022
InvestorsHub NewsWire

Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection Delta Variant

 Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection Delta Variant TORONTO, November 16, 2021 -- InvestorsHub NewsWire -- Revive...

16 Novembre 2021
InvestorsHub NewsWire
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.00025-4.166666666670.0060.00670.0053896110.00609381CS
4-0.00025-4.166666666670.0060.007780.0054350380.00624987CS
12-0.00035-5.737704918030.00610.0120.0054985570.00695086CS
26-0.00625-52.08333333330.0120.01350.0053782510.00741118CS
52-0.01825-76.04166666670.0240.0360.0053553450.01327006CS
156-0.24425-97.70.250.390.0054322330.10733635CS
260-0.02975-83.80281690140.03550.720.00510596540.275585CS

RVVTF - Frequently Asked Questions (FAQ)

What is the current Revive Therapeutics (QB) share price?
The current share price of Revive Therapeutics (QB) is US$ 0,00575
How many Revive Therapeutics (QB) shares are in issue?
Revive Therapeutics (QB) has 418 564 269 shares in issue
What is the market cap of Revive Therapeutics (QB)?
The market capitalisation of Revive Therapeutics (QB) is USD 2,32M
What is the 1 year trading range for Revive Therapeutics (QB) share price?
Revive Therapeutics (QB) has traded in the range of US$ 0,005 to US$ 0,036 during the past year
What is the PE ratio of Revive Therapeutics (QB)?
The price to earnings ratio of Revive Therapeutics (QB) is -5,97
What is the reporting currency for Revive Therapeutics (QB)?
Revive Therapeutics (QB) reports financial results in CAD
What is the latest annual profit for Revive Therapeutics (QB)?
The latest annual profit of Revive Therapeutics (QB) is CAD -5,62M
What is the registered address of Revive Therapeutics (QB)?
The registered address for Revive Therapeutics (QB) is 82 RICHMOND STREET EAST, SUITE 105, TORONTO, ONTARIO, M5C 1P1
What is the Revive Therapeutics (QB) website address?
The website address for Revive Therapeutics (QB) is www.revivethera.com
Which industry sector does Revive Therapeutics (QB) operate in?
Revive Therapeutics (QB) operates in the UNIT INV TR, CLOSED-END MGMT sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CRMBQCrumbs Bake Shop Inc (CE)
US$ 0,012
(11 900,00%)
500
MMATQMeta Materials Inc (CE)
US$ 0,0001
(9 900,00%)
336
ISUNQiSun Inc (CE)
US$ 0,0001
(9 900,00%)
5,22k
FCGDFirst Colombia Gold Corporation (PK)
US$ 0,0001
(9 900,00%)
1,6M
PPJEPPJ Healthcare Enterprises Inc (PK)
US$ 0,0001
(9 900,00%)
1,16M
RAASYCloopen Group Holding Limited (CE)
US$ 0,000001
(-100,00%)
1,27k
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0,000001
(-99,99%)
4,9k
CCFLUCCF Holdings LLC (CE)
US$ 0,0002
(-99,20%)
4,91k
NWTTNW Tech Capital Inc (PK)
US$ 0,000001
(-99,00%)
100k
FUVVArcimoto Inc (CE)
US$ 0,000001
(-99,00%)
522
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,0039
(2,63%)
551,86M
HMBLHUMBL Inc (PK)
US$ 0,00095
(5,56%)
223,83M
RDARRaadr Inc (PK)
US$ 0,00115
(-8,00%)
146,07M
IJJPIJJ Corporation (PK)
US$ 0,0004
(14,29%)
77,21M
AURIAuri Inc New (PK)
US$ 0,0002
(-20,00%)
77,09M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
RVVTF
Revive Therapeutics (QB)
TSX
HAZ
Global X Active Global D...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés